| INTRODUCTION
Exertional rhabdomyolysis (ER) in horses is characterized by multiple episodes of stiffness, muscle cramping, reluctance to move, and muscle damage and can have many causes. 1 Exertional rhabdomyolysis affects 5%-7% of Thoroughbred (TB) and Standardbred (STD) racehorses, and recurrence can be so frequent that 17% of ER horses are unable to race again in the same season. [2] [3] [4] The term recurrent exertional rhabdomyolysis (RER) has been used to describe a chronic form of ER in racehorses with a proposed underlying cause of abnormal myoplasmic calcium (Ca 2+ ) regulation. 5, 6 This hypothesis was based on finding a lower threshold for inducing a contracture in isolated skeletal muscle bundles of RER versus control horses exposed to increasing concentrations of halothane, potassium, and caffeine, all of which induce Ca 2+ release from the sarcoplasmic reticulum (SR). 5, 6 In addition, higher caffeine-induced Ca 2+ release was found in cultured myotubes from RER versus control horses, as detected by Fura-2 fluorescence imaging. 7 Further studies of isolated SR membranes and genetic linkage analysis have not identified an underlying cause for alterations of Ca 2+ regulation in RER. 8, 9 Recent discoveries regarding fundamental modes of intracellular Ca 2+ regulation have identified additional regulatory mechanisms for the SR Ca 2+ transporting ATPase (SERCA) that may play a role in the genesis of RER in horses. After contraction, SERCA induces muscle relaxation by catalyzing the transport of 2 Ca 2+ ions into the lumen of the SR using the free energy from hydrolysis of 1 ATP molecule. Phospholamban (PLN) inhibits SERCA activity and is primarily expressed in cardiac and slow twitch muscle fibers. 10, 11 Sarcolipin (SLN), first discovered in 1974 as a peptide that copurifies with SERCA, was subsequently found to decrease the Ca 2+ affinity of SERCA 12 and decrease the energetic coupling efficiency of SERCA (Ca 2+ /ATP transport ratio <2), thereby decreasing SR luminal Ca 2+ stores. [12] [13] [14] In addition, transcripts that previously were annotated as long noncoding RNAs recently have been found to encode small transmembrane peptides
MRLN and dwarf open reading frame (DWORF) that also regulate the activity of SERCA in skeletal muscle ( Figure 1 ). 15, 16 Dwarf open reading frame has been shown to enhance SERCA activity in the mouse heart by displacing PLN and, in cell culture models, by displacing SLN and 2 | METHODS
MRLN (Figure 1
)
| Pilot study
To determine if SERCA1 (expressed in fast twitch type 2 fibers) or SERCA2 (expressed in cardiac and type 1 muscle fibers) was primarily expressed in equine gluteal muscle, we initially evaluated transcripts per million reads from RNA-seq data obtained from gluteal muscle of 6 healthy Arabian horses (NCBI's Gene Expression Omnibus GEO Series accession number GSE104388). Mean transcripts per million reads (SD) were 3.7 times higher for SERCA1 (562 ± 152 TPM) than SERCA2 (243 ± 145 TPM). When muscle fiber type composition was assessed for 6 of the TBs in our study, we found they had 50% fewer type 1 fibers than did the Arabian horses used in the RNA-seq analyses (TB: 8% ± 3% type 1, 92% ± 5% type 2: Arabian 17% ± 3% type 1, 83% ± 8% type 2). Thus, SERCA1 rather than SERCA2 seemed to be the primary isoform of interest when studying SERCA inhibitors in TB gluteal muscle.
The study was approved by the Institutional Animal Use and Care
Committee of Michigan State University.
| Comparative amino acid sequences
The entire coding sequences for SLN and MRLN were identified from the annotated references genomes of horse (EquCab2; http://ncbi. Table 1 ). The RER criteria included a history of repeated episodes of ER reported by the referring veterinarian and muscle biopsy specimens with normal periodic acid-Schiff's (PAS) staining for glycogen. Preference for study inclusion was given to horses with numerous episodes of ER, documented increases in serum creatine kinase (CK) activity and centrally displaced nuclei on histological examination (Supplemental Table 1 ). All QH examined were negative for the glycogen synthase 1 (GYS1) mutation responsible for type 1 polysaccharide storage myopathy. 17 Control horses had no known history of ER and, for TB and QH, no evidence of muscle histopathology. Hair samples rather than muscle biopsy specimens were available from local STD racehorse controls.
| DNA isolation and sequencing
Qiagen DNeasy Blood and Tissue Kit (Qiagen, Germantown, Maryland) was used to isolate genomic DNA from hair roots, buffy coat, or frozen muscle samples according to the manufacturer's protocol.
| Primers
Primers were designed using Primer3Plus software 18 to cover the pre- Table 2 ). The regions sequenced for SLN comprised 6332 bp. For MLRN, 4 primers were designed to cover noncoding exon 1, possible noncoding exon 2, noncoding exon 3, and coding exon 4 (Supplemental Table 2 ). The region sequenced for MRLN comprised 2747 bp. For DWORF, based on the open reading frame that begins in exon 1 and encodes the first 4 AA of the protein with the remaining protein being encoded in exon 2, 2 primers were designed to cover 500 bp upstream of the coding sequence, the first 4 AA in exon 1, and exon 2 and the 3 0 untranslated region. 15 The region sequenced for DWORF comprised 1300 bp. Primers are listed in Supplemental Table 2 .
| PCR and sequence analysis
Each primer pair was used to amplify intervening genomic DNA using Table 1 ). The RER horses had a history of episodes of ER documented by a veterinarian and had not exhibited clinical signs within 48 hours of muscle biopsy. Control horses were in training and had no history of ER. Twelve of the horses used for gene expression studies also were Sanger sequenced for SLN as described above.
| Primers
Primers for GAPDH, RYR1, SERCA1, CASQ1, DWORF, PLN, MRLN, SLN, and FKBP1A were designed to cross exon-exon boundaries using NCBI (https://www.ncbi.nlm.nih.gov/tools/primer-blast/) and referencing NCBI EquCab 2.0 (Supplemental Table 3 ). The glyceraldehyde phosphate dehydrogenase (GAPDH) gene was used as a housekeeping control because it showed minimal variability and is less variable across age in skeletal muscle. 19 
| Muscle biopsies
Gluteus medius muscle biopsy specimens were obtained in the morning 1-4 hours after jogging or light galloping exercise from a standardized site using a modified Bergstrom biopsy needle as previously described. 20 A portion of the sample was flash-frozen in liquid nitrogen and stored at −80 C. A second portion was oriented in crosssection and frozen within 12 hours of sampling in isopentane that was suspended in liquid nitrogen.
| Muscle histopathology
Cryostat sections (7-μm thick) were stained with hematoxylin and eosin and PAS and evaluated for the presence of centrally located nuclei, degenerating myofibers, or macrophages. 21 
| RNA extraction
Total muscle RNA was isolated from flash frozen samples using TRIzol/chloroform extraction after tissue homogenization with a biopulverizer (BioSpec Products, Inc, Fartlesville, Oklahoma) as previously described. 22 Treatments with DNase were performed on columns 
| Complementary DNA synthesis
Complementary DNA (cDNA) was made using a high-capacity cDNA reverse transcription kit (Applied Biosystems 
| Dwarf open reading frame
The DWORF peptide was similar in length between horse and human at 35 AA and was 34 AA in mouse with 3 AA that could not be deduced from the rabbit reference genome (Figure 2 
| Coding sequence of SLN, MRLN, DWORF in RER and control horses
No differences were detected in coding sequences of SLN, MRLN, and DWORF between RER and control horses.
| Gene expression
Sarcolipin was the most highly expressed SERCA regulatory gene (Table 1 ). No significant difference was found in the expression level of Ca 2+ regulatory genes between control females and control males or between RER females and control females ( Figure 3 ). An impact of sex and phenotype was observed in which RER males had significantly higher expression of FKBP1A (P = .01) than did control males ( Figure 3 ). The RER males had lower expression of CASQ1 than did control females (P < .001) and lower expression than RER females (P = .05; Figure 3 ).
FIGURE 2
Amino acid sequence (AA) of SLN, PLN, MRLN, and DWORF derived from mouse, human, and rabbit reference genomes, and Sanger sequencing of horse genes in the present study. Yellow highlight indicates AA substitution or deletion unique to horse. Green highlight indicates highly conserved residues near the myoplasmic-membrane interface of SERCA inhibitory peptides. 16 34 In addition, the luminal tail of SLN in the horse was missing the terminal Tyr, which is proposed to functionally interact with luminal residues in SERCA and to target SLN to the SR and endoplasmic reticulum. 39, 42, 43 Notably, the 29 AA equine SLN sequence is also found in zebra and ass, (ERX607036 and ERX607001) and Przewalski's horse but not in another Perisodactyl, the Southern white rhinoceros. Thus, the distinct SLN sequence of Equus sp. has been present for millions of years, before the divergence of Equus caballus, Equus przewalski, Equus grevi, and Equus asinus, and suggests a unique mechanism for myoplasmic Ca 2+ regulation in the horse. 44 A selection advantage for RER is suggested by the fact that STD horses with RER have faster racing times from a standing start than do STD without RER and by the high prevalence of RER in STD and TB at 5%-7%. 2, 3 Small increases in myoplasmic Ca 2+ concentration during muscle relaxation induced by the unique protein sequence of equine SLN could provide a selection advantage to horses with their superior athletic capacity by facilitating Ca 2+ entry into mitochondria (which activates ATP production and metabolic processes), activating Ca 2+ -dependent signaling pathways important for programming an oxidative muscle phenotype, and increasing the power of muscle contraction by initial enhancement of actomyosin force production. 45 Whereas slight increases in myoplasmic Ca 2+ could enhance speed and endurance, excessive increases in myoplasmic Ca 2+ lead to persistent myofiber contracture, enhanced reactive oxygen production, activation of proteases, and myodegeneration. 46 Thus, in horses, it is possible that slight alterations in the regulation of myoplasmic Ca 2+ result in a fine balance between enhanced speed on the 1 hand and RER on the other.
The distinctive sequence of equine SLN made it a potential candidate gene for RER. However, no differences in SLN coding sequence were detected among 18 TB, 5 STD, and 6 QH with RER versus control horses. Coding sequences of MRLN and its inhibitor DWORF also were evaluated in a small number of horses, but no mutation associated with RER was identified. Additional resources were not directed to sequence more horses for MRLN and DWORF, because those RER horses that were sequenced had repeated episodes of ER of sufficient concern to submit muscle biopsy samples but no mutations were found. Multiple causes for RER may exist, some of which may be breed specific, and individual horses may have mutations in genes that
were not evaluated in our study. However, based on our results, we propose that there is no high-frequency coding mutation in SERCA ). The SLN and CASQ1 genes were not included in the array, and ATP2A1 was found to be upregulated in the same samples using qRT-PCR. These results are difficult to compare with our study especially because they were not stratified according to sex and because the 2 studies sampled RER muscle at different times: between episodes versus within 1 day of an ER episode.
A sex bias exists for the expression of RER with males being less prone to RER than females. 3, 4 It is noteworthy that sex-specific differences in Ca 2+ regulatory gene expression were found in RER horses in our study. For example, RER males had lower expression of CASQ1 than did RER females (P = .05) and control females (P < .001). A sex effect of CASQ1 expression and muscle disease is seen in murine models in which male CASQ1-null mice developed fatal stress-induced malignant hyperthermic-like reactions, whereas female CASQ1-null mice were protected. 51, 52 Calsequestrin is integral in regulating RYR1 Further experiments using a customized anti-horse-SLN antibody would be necessary to correlate SLN gene and protein expression. The notable RER sex-specific difference in CASQ1 and FKBP1A expression was an unexpected finding in our study, and further experiments are needed to examine their impact on RER in males and females.
In conclusion, our results show that the Equus species has a novel SLN AA sequence with the potential for unique regulation of the Ca 
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